A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease
published in: Pediatric Research
date of publication: 2011-08-01
language: English
main subject: hemodynamics, randomized controlled trial
Cites articles 14
Date
Title
Article - wd:Q45367066